Dynamic Control of Oligosaccharide Modification in the Mammary Gland: Linking Recombinant Human Erythropoietin
- 1 February 2006
- journal article
- research article
- Published by Springer Nature in Transgenic Research
- Vol. 15 (1) , 37-55
Abstract
We analyzed two transgenic mouse lines that secrete rhEPO in their milk to assess the dynamic control of N-linked oligosaccharides. Since pharmaceutically available epoetin α and β are produced in CHO cells, we compared transgenic mammary gland-derived rhEPO to its CHO cell-derived counterpart. The major glycosyltransferases that determine the N-oligosaccharides patterns of rhEPO include N-acetylglycosaminyltransferase (GnT) and α1,3/4 fucosyltransferase (Fuc-TIV), GnT-III, -V and Fuc-TIV expression in the mouse mammary gland is significantly higher than that in Chinese hamster ovary (CHO)-derived cells, where the protein is not detectable. The data suggest that N-linked sugar chain patterns of recombinant glycoproteins, produced by the mammary gland differ, since GnT-III alters the sugar pattern extensively. In our experiments, rhEPO produced by the transgenic mice contains more tetra-acidic oligosaccharide structures than epoetin α derived from CHO cells, a rhEPO that is widely used therapeutically. Accordingly, we examined milk-derived rhEPO activity, both in vitro and in vivo. The rhEPO protein purified from the milk of mammary glands upregulates the EPO receptor-mediated expression of the STAT5 gene in MCF-7 cells in a dose-dependent manner, similar to the effects of epoetin α. Furthermore, direct injection of rhEPO into the mouse tail vein leads to an increase in the levels of blood components, such as red blood cells and platelets. In light of these findings, we suggest that the mammary glands of transgenic animals provide a sufficient environment to generate rhEPO with post-translational modifications for biopharmaceutical use.Keywords
This publication has 65 references indexed in Scilit:
- Murine male germ cell apoptosis induced by busulfan treatment correlates with loss of c‐kit‐expression in a Fas/FasL‐ and p53‐independent mannerFEBS Letters, 2004
- HPCE Monitoring of the N-Glycosylation Pattern and Sialylation of Murine Erythropoietin Produced by CHO Cells in Batch ProcessesBiotechnology Progress, 2004
- The Cellular Biology of Erythropoietin ReceptorsThe Oncologist, 2003
- Two-dimensional electrophoresis of recombinant human erythropoietin: A future method for the European Pharmacopoeia?Proteomics, 2002
- Cloning, sequencing, and expression analysis of the porcine uroplakin II geneBiochemical and Biophysical Research Communications, 2002
- Erythropoietin Can Induce the Expression of Bcl-xLthrough Stat5 in Erythropoietin-dependent Progenitor Cell LinesJournal of Biological Chemistry, 1999
- Epoetin alpha and beta in their erythropoetin isoform compositions and biological propertiesBritish Journal of Haematology, 1998
- Comparisons of human, rat and mouse erythropoietins by isoelectric focusing: differences between serum and urinary erythropoietinsBritish Journal of Haematology, 1991
- Molecular charge heterogeneity of human serum erythropoietinBritish Journal of Haematology, 1990
- Isolation and characterization of genomic and cDNA clones of human erythropoietinNature, 1985